For: | Vislovukh A, Vargas TR, Polesskaya A, Groisman I. Role of 3’-untranslated region translational control in cancer development, diagnostics and treatment. World J Biol Chem 2014; 5(1): 40-57 [PMID: 24600513 DOI: 10.4331/wjbc.v5.i1.40] |
---|---|
URL: | https://www.wjgnet.com/1949-8454/full/v5/i1/40.htm |
Number | Citing Articles |
1 |
Xiaoli Yuan, Rongjun Ma, Shiwei Yang, Li Jiang, Zhen Wang, Zunmin Zhu, Hongwei Li. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1. Cell Cycle 2019; 18(14): 1660 doi: 10.1080/15384101.2019.1632138
|
2 |
Dorra BenAyed-Guerfali, Chamseddine Kifagi, Wala BenKridis-Rejeb, Nihel Ammous-Boukhris, Wajdi Ayedi, Afef Khanfir, Jamel Daoud, Raja Mokdad-Gargouri. The Identification by Exome Sequencing of Candidate Genes in BRCA-Negative Tunisian Patients at a High Risk of Hereditary Breast/Ovarian Cancer. Genes 2022; 13(8): 1296 doi: 10.3390/genes13081296
|
3 |
Marewan Abid, Fikry Qadir, Abbas Salihi. Association between the serum concentrations and mutational status of IL‑8, IL‑27 and VEGF and the expression levels of the hERG potassium channel gene in patients with colorectal cancer. Oncology Letters 2021; 22(3) doi: 10.3892/ol.2021.12926
|
4 |
Barbara Hernando, Maria Peña‐Chilet, Maider Ibarrola‐Villava, Manuel Martin‐Gonzalez, Cristina Gomez‐Fernandez, Gloria Ribas, Conrado Martinez‐Cadenas. Genetic 3′UTR variation is associated with human pigmentation characteristics and sensitivity to sunlight. Experimental Dermatology 2017; 26(10): 896 doi: 10.1111/exd.13333
|
5 |
Jelena Kresoja-Rakic, Merve Sulemani, Michaela B. Kirschner, Manuel Ronner, Glen Reid, Steven Kao, Beat Schwaller, Walter Weder, Rolf A. Stahel, Emanuela Felley-Bosco. Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma. Frontiers in Genetics 2017; 8 doi: 10.3389/fgene.2017.00070
|
6 |
Jahangir Abdi, Hou Jian, Hong Chang. Role of micro-RNAs in drug resistance of multiple myeloma. Oncotarget 2016; 7(37): 60723 doi: 10.18632/oncotarget.11032
|
7 |
Xiaoling Zhong, Shikun Lei, Jing-Wen Lin, Min Ren, Min Shu. Aberrant expression of long non-coding RNAs in peripheral blood mononuclear cells response to tuberculosis in children. Medicine 2022; 101(42): e31065 doi: 10.1097/MD.0000000000031065
|
8 |
XIN DENG, YI ZHAO, BAOSHENG WANG. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression. Oncology Reports 2015; 34(4): 2188 doi: 10.3892/or.2015.4160
|
9 |
Li Lin, Hongwei Liang, Yanbo Wang, Xiaomao Yin, Yanwei Hu, Jinlan Huang, Tingyu Ren, Hui Xu, Lei Zheng, Xi Chen. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-879
|
10 |
Haifei Chen, Weiling Cao, Jiao Chen, Danbo Liu, Lingyun Zhou, Fang Du, Feiqi Zhu. miR‐218 contributes to drug resistance in multiple myeloma via targeting LRRC28. Journal of Cellular Biochemistry 2021; 122(3-4): 305 doi: 10.1002/jcb.29684
|
11 |
Kai Liu, Ben-Jun Wang, WeiWei Han, Chun-Hua Chi, Chao Gu, Yu Wang, Xiaohai Fu, Wei Huang, Zhiguo Liu, Xilin Song. CFIm25-regulated lncRNA acv3UTR promotes gastric tumorigenesis via miR-590-5p/YAP1 axis. Oncogene 2020; 39(15): 3075 doi: 10.1038/s41388-020-1213-8
|
12 |
Roberta Cacioppo, Catherine Lindon. Regulating the regulator: a survey of mechanisms from transcription to translation controlling expression of mammalian cell cycle kinase Aurora A. Open Biology 2022; 12(9) doi: 10.1098/rsob.220134
|
13 |
Savita Singh, Girish C. Shukla, Sanjay Gupta. MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer. Current Pharmacology Reports 2015; 1(2): 79 doi: 10.1007/s40495-014-0009-3
|
14 |
Sura Al-Asadi, Hiba Mansour, Ahmed Jwaid Ataimish, Rusul Al-Kahachi, Jamila Rampurawala. MicroRNAs Regulate Tumorigenesis by Downregulating SOCS3 Expression: An In silico Approach. Bioinformatics and Biology Insights 2023; 17 doi: 10.1177/11779322231193535
|
15 |
Xu Zhou, Hua-qiang Zhu, Chao-qun Ma, Hong-guang Li, Fang-feng Liu, Hong Chang, Jun Lu. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression. Biomedicine & Pharmacotherapy 2016; 79: 315 doi: 10.1016/j.biopha.2016.02.025
|
16 |
Michaela Kuhlen, Julia Taeubner, Triantafyllia Brozou, Dagmar Wieczorek, Reiner Siebert, Arndt Borkhardt. Family-based germline sequencing in children with cancer. Oncogene 2019; 38(9): 1367 doi: 10.1038/s41388-018-0520-9
|
17 |
Zhongshu Zhai, Wanhong Chen, Qiaosheng Hu, Xin Wang, Qing Zhao, Muhadasi Tuerxunyiming. High glucose inhibits osteogenic differentiation of bone marrow mesenchymal stem cells via regulating miR-493-5p/ZEB2 signalling. The Journal of Biochemistry 2020; 167(6): 613 doi: 10.1093/jb/mvaa011
|
18 |
Zhengjun Yi, Jianhua Li, Kunshan Gao, Yurong Fu. Identifcation of differentially expressed long non-coding RNAs in CD4+ T cells response to latent tuberculosis infection. Journal of Infection 2014; 69(6): 558 doi: 10.1016/j.jinf.2014.06.016
|
19 |
Carolina Colleti, Talita Diniz Melo-Hanchuk, Flávia Regina Moraes da Silva, Ângela Saito, Jörg Kobarg. Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions. World Journal of Biological Chemistry 2019; 10(3): 44-64 doi: 10.4331/wjbc.v10.i3.44
|
20 |
Z. Yang, Y. Han, K. Cheng, G. Zhang, X. Wang. miR‐99a directly targets the mTOR signalling pathway in breast cancer side population cells. Cell Proliferation 2014; 47(6): 587 doi: 10.1111/cpr.12146
|
21 |
Hakan Kucuksayan, Sakir Akgun, Osman Nidai Ozes, Arsenal Sezgin Alikanoglu, Mustafa Yildiz, Egemen Dal, Hakan Akca. TGF-β–SMAD–miR-520e axis regulates NSCLC metastasis through a TGFBR2-mediated negative-feedback loop. Carcinogenesis 2019; 40(5): 695 doi: 10.1093/carcin/bgy166
|
22 |
Ali Al-Fatlawi, Negin Malekian, Sebastián García, Andreas Henschel, Ilwook Kim, Andreas Dahl, Beatrix Jahnke, Peter Bailey, Sarah Naomi Bolz, Anna R. Poetsch, Sandra Mahler, Robert Grützmann, Christian Pilarsky, Michael Schroeder. Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants. Cancers 2021; 13(11): 2654 doi: 10.3390/cancers13112654
|
23 |
Yiping Zhang, Meiwen Yang, Shulong Yang, Fenfang Hong. Role of noncoding RNAs and untranslated regions in cancer: A review. Medicine 2022; 101(33): e30045 doi: 10.1097/MD.0000000000030045
|
24 |
Nagisa Nosrati, Marica Bakovic, Gopinadhan Paliyath. Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds. International Journal of Molecular Sciences 2017; 18(10): 2050 doi: 10.3390/ijms18102050
|
25 |
Israa Dib, Alia Khalil, Racha Chouaib, Yolla El-Makhour, Hiba Noureddine. Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies. Molecular Biology Reports 2021; 48(1): 875 doi: 10.1007/s11033-020-06071-5
|
26 |
Sara Abdolahi, Ameneh Zare-Chahoki, Farshid Noorbakhsh, Ali Gorji. A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders. Molecular Neurobiology 2022; 59(10): 6260 doi: 10.1007/s12035-022-02966-5
|
27 |
ZHUANGQING YANG, DEDIAN CHEN, JIANYUN NIE, SHAOQIANG ZHOU, JIANKUI WANG, QI TANG, XIAOJUAN YANG. MicroRNA-143 targets CD44 to inhibit breast cancer progression and stem cell-like properties. Molecular Medicine Reports 2016; 13(6): 5193 doi: 10.3892/mmr.2016.5194
|
28 |
|
29 |
Animesh Hatibaruah, Mizanur Rahman, Satyakam Agarwala, Seram Anil Singh, Suruchi Gupta, Prosenjit Paul. Circular RNAs in cancer and diabetes. Journal of Genetics 2021; 100(2) doi: 10.1007/s12041-021-01268-4
|
30 |
Weiguo Sui, Can Zheng, Ming Yang, Minglin Ou, Jiejing Chen, Li Dong, Peng Chen, Xianliang Hou, Fuhua Liu, Xiaolian Wei, Yong Dai. Study on 3′-UTR length polymorphism in peripheral blood mononuclear cells of uremia patient. Renal Failure 2016; 38(1): 96 doi: 10.3109/0886022X.2015.1104989
|
31 |
Ji-Kai She, Dan-Ni Fu, Dong Zhen, Guo-Hua Gong, Bin Zhang. <p>LINC01087 is Highly Expressed in Breast Cancer and Regulates the Malignant Behavior of Cancer Cells Through miR-335-5p/Rock1</p>. OncoTargets and Therapy 2020; : 9771 doi: 10.2147/OTT.S255994
|